Beyond rare pathogenic mutations, single-nucleotide polymorphisms (SNPs) in BARD1 have also emerged as important regulators of cancer susceptibility, particularly highlighted in neuroblastoma, nephroblastoma, and gynecologic malignancies [58,59]. The gene discussed is BARD1; the disease is neuroblastoma.